RankingsPricing
  1. US-listed companies
  2. NORTHWEST BIOTHERAPEUTICS INC
  3. Raw

NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$345.05M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Research and other-------------1
Research and development9011916386103603418-----35
General and administrative75911031725111223-----33
Total operating costs and expenses172216273103128805545-----68
Loss from operations-27-44-57-101-126-79-55-41------67
Derivative, Gain (Loss) on Derivative, Net--3-151618-31812-435239-2640
Change in fair value of share payable-----------0-00
Change in fair value of convertible notes-------------28
Loss from extinguishment of debt------1-130-2-2-0-3-5-14
Loss from issuance of debt--------------1
Loss from warrant modification--------------1
Interest expense-------------8
Foreign currency transaction gain (loss)----0-75-3------2
Total other expense-------6------17
Net loss-33-67-66-136-115-80-73-36-20-530179-105-63-84
Deemed dividend related to warrant modifications-----6-------1
Net loss attributable to common stockholders-33-67-66---86-74-54------85
Foreign currency translation adjustment--------------2
Total comprehensive loss--------------84
Earnings Per Share, Basic-0.35-------------0.07
Earnings Per Share, Diluted-0.35-------------0.07